Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Betr Reimagines the Over-The-Counter Medication Market with the Launch of Direct-to-Consumer Brand

The Brand Seeks To Disrupt The Stale, $35b Category Through Its Convenient, Effective and Radically Transparent Products Designed to Help the World Feel Betr.


News provided by

Betr Remedies

Mar 11, 2021, 08:08 ET

Share this article

Share toX

Share this article

Share toX

SANTA MONICA, Calif., March 11, 2021 /PRNewswire/ -- Betr—a socially conscious company that produces high-quality, over-the-counter medicine—launches today with medications aimed to help people feel their best while also helping others. Betr is simplifying the over-the-counter space and offering high-quality products that alleviate the most common ailments— starting with pain and allergies—offering everything most consumers need, and nothing they don't, shipped right to their door. Betr is putting the customer first; a radical concept for the category. Coupled with a give-back program that lies at the heart of the business, consumers now have an opportunity to consciously shop for over-the-counter medications for themselves and in turn provide a life-saving medication for someone who could not otherwise afford it.

Continue Reading

Launched to help cut through the noise of an unnecessarily complicated pharmacy shelf, Betr curates its products into selected bundles that include the over-the-counter products most commonly used together for each category—starting with pain and allergy.

Betr is brought to market by co-founders Livio Bisterzo of Green Park Brands, a life-long entrepreneur with an expertise in consumer packaged goods, and Jen Hoffman, an industry veteran and business leader with decades of experience in drug manufacturing, along with a team of purpose driven entrepreneurs, and is backed by multi-national CPG conglomerate Reckitt Benckiser (RB), a pre-seed investor.

"We have a real opportunity to change the way consumers shop for over-the-counter medications, by simplifying the assortment, empowering consumers with the information they need to make the right buying decisions, and communicating with warmth and heart," says Hoffman. "We are well positioned to radically elevate the experience in this category. Through our initial direct-to-consumer approach, we will get to know the consumer more intimately and put them at the center as we learn and evolve to support their selfcare journey."

Driven by purpose as well as efficacy, Betr believes that everyone should have access to the medications they need, so every time you purchase Betr, you are helping those who so often are forced to go without. Even before the COVID-19 pandemic, 1 in 4 Americans could not afford their prescription medications.

Each year, $10 billion dollar's worth of perfectly good, unused medications is sent to a medical waste incinerator to be destroyed. Betr's give-back program aims to deliver real impact on both fronts. Working strategically with a non-profit partner, Betr will donate 4% of their net revenue to facilitate the distribution of unused prescription medications to medical networks serving underserved communities. Every over-the-counter Betr bundle purchased equals one prescription donated. Betr aims to donate 10 million prescriptions in four years, worth over $400 million dollars for underserved communities.

"Change in the real world requires action, not just a corporate narrative. With Betr, we were able to create a socially conscious approach to over-the-counter medication by integrating a meaningful give-back partnership at the heart of our business model," says Bisterzo. "We have a unique opportunity to help people in need, while promoting a new consumerism that will benefit more people by being fairer, more equitable, and more sustainable."

FMCG company Reckitt Benckiser (RB) has led the pre-seed investment—its London-based ventures arm backs early-stage startups and founders who share RB's 'fight for access,' making high-quality hygiene, health and nutrition a right, not a privilege. Betr's radical customer-first approach, coupled with its give-back program that enables consumers to consciously shop for medications and in turn, provide a life-saving medication for someone who could not otherwise afford it, fueled the purpose-backed investment.

"We are thrilled to partner with the team at Betr and be a part of their goal in striving to make high-quality medicine accessible to all," says Rakesh Narayana, Global Director of New Ventures at RB. "Access to high-quality health and hygiene is something we are passionate about at RB and this continues to be a focus on the strategic investments and partnerships that we make. By leveraging both RB and Betr's expertise and our complementary strengths, the partnership is challenging the status quo and bringing effective and radically transparent over-the-counter products to a discerning and socially minded consumer."

Betr's products are manufactured in partnership with a Michigan-based drug manufacturer that has 125 years of experience making over-the-counter medications. In fact, Betr products contain the same active ingredients—and the same quality and safety expectations—as the name brands customers are used to seeing on the shelves.

Betr empowers its consumers with clear, concise information about its products—it's easy to understand everything that goes into the brand's medications and how they'll help customers feel better. Betr's radical transparency extends to its Transparency Tool, where consumers can enter a 7 digit code on the back of their product to see when their specific product was packaged, its expiration date, and quality test results.

To launch, the brand is focusing on pain and allergy. The following over-the-counter medications are now available exclusively on www.betrremedies.com:  

  • Pain
    • Pain Relief Tablet (active ingredient— Ibuprofen)
    • Pain Relief Caplet (active ingredient— Acetaminophen)
    • Sleep Aid Tablet (active ingredient— Diphenhydramine)
    • Headache Relief Tablet ( active ingredient— Naproxen Sodium)
  • Allergy
    • All Day Allergy Relief Tablet (active ingredient— Cetirizine Hydrochloride)
    • Allergy Relief Tablet (active ingredient— Diphenhydramine)
    • Nasal Spray (active ingredient— Fluticasone Propionate Glucocorticoid)

Consumers can purchase as single products or as curated pain and allergy bundles to ensure they have a variety of medications to help best treat their symptoms.

For further information, please contact:
Travis Paul Martin [email protected]  
Sophie Williams [email protected]  
Allison Hogan [email protected]

About Betr 
Betr, a socially conscious company that produces high-quality, FDA-approved, over-the-counter medicine, is on a mission to help people feel their best while also helping others. By simplifying the over-the-counter space and offering high-quality products that alleviate the most common ailments, Betr offers everything most consumers need, and nothing they don't, shipped right to their door. And Betr's give-back program is at the heart of the brand—every over-the-counter bundle purchased equals one prescription donated for a person who needs it. Founded by Livio Bisterzo, experienced entrepreneur and CEO of Green Park Brands, and Jen Hoffman, an industry veteran and business leader with decades of experience in drug manufacturing, Betr is revolutionizing over-the-counter medication for today's consumer through a more socially conscious and sustainably minded lens. For more information, visit www.betrremedies.com, and follow along on Instagram @betrremedies.

About Reckitt Benckiser
RB* is driven by its purpose to protect, heal and nurture in a relentless pursuit of a cleaner, healthier world. We fight to make access to the highest-quality hygiene, wellness and nourishment a right, not a privilege, for everyone.

RB is proud to have a stable of trusted household brands found in households in more than 190 countries. These include Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite, Air Wick and more.  20 million RB products a day are bought by consumers globally.

RB's passion to put consumers and people first, to seek out new opportunities, to strive for excellence in all that we do, and to build shared success with all our partners, while doing the right thing, always is what guides the work of our 40,000+ diverse and talented colleagues worldwide.

For more information visit www.rb.com

*RB is the trading name of the Reckitt Benckiser group of companies

SOURCE Betr Remedies

Related Links

https://betrremedies.com

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.